Labat Africa (JSE:LAB) Total Stockholders Equity: R190.4 Mil (As of Nov. 2025)


What is Labat Africa Total Stockholders Equity?

Labat Africa JSE:LAB Total Stockholders Equity is R190.4 Mil as of Nov. 2025. The stock has 5 warning signs investors should review.

Labat Africa's Total Stockholders Equity for the quarter that ended in Nov. 2025 was R190.4 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Labat Africa's Book Value per Share for the quarter that ended in Nov. 2025 was R0.15. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Labat Africa's Debt-to-Equity for the quarter that ended in Nov. 2025 was 0.10.

Labat Africa  (JSE:LAB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Labat Africa's Book Value per Share for the quarter that ended in Nov. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(190.363-0)/1246.065
=0.15

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Labat Africa's Debt-to-Equity for the quarter that ended in Nov. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(10.745 + 9.101) / 190.363
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labat Africa Total Stockholders Equity Related Terms

Labat Africa Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Labat Africa's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labat Africa Total Stockholders Equity Chart

Labat Africa Annual Data
Trend Feb14 Feb15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 May23 May24
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.43 69.79 91.59 0.42 -23.80

Labat Africa Semi-Annual Data
Aug15 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.21 -23.80 -16.18 145.84 190.36
What does a Total Stockholders Equity of R190.4 Mil mean?
Labat Africa (JSE:LAB) has a Total Stockholders Equity of R190.4 Mil as of Nov. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Labat Africa and its competitors.
Is Labat Africa's Total Stockholders Equity too high?
Labat Africa's current Total Stockholders Equity is R190.4 Mil.
How does Labat Africa's Total Stockholders Equity compare to ZTS and UTHR?
Labat Africa's Total Stockholders Equity of R190.4 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Labat Africa and its competitors. Labat Africa's current Total Stockholders Equity is R190.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.18, compared to a current price of R0.03 — trading 83.3% below its estimated fair value. The current Total Stockholders Equity is R190.4 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current Total Stockholders Equity is R190.4 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Labat Africa Business Description

Other Exchanges LAO:Germany
Address 75 Maude StreetSandown, The Leonardo 14th Floor, Sandown, Johannesburg, GT, ZAF, 1709
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.